Urease inhibitory profile of extracts and chemical constituents of Pistacia atlantica ssp. cabulica Stocks.

The current study was designed to evaluate the urease inhibitory profile of extract and fractions ofPistacia atlanticassp. cabulica Stocks followed by bioactivity-guided isolated compounds. The crude extract was found significantly active with urease inhibitor (95.40% at 0.2 mg/mL) with IC50values o...

Descripción completa

Detalles Bibliográficos
Publicado en:Natural Product Research Vol. 30; no. 12; pp. 1411 - 1417
Autores principales: Uddin, Ghias, Ismail, Rauf, Abdur, Raza, Muslim, Khan, Haroon, Nasruddin, Khan, Majid, Farooq, Umar, Khan, Ajmal, Arifullah
Formato: Journal Article
Publicado: Taylor & Francis Ltd Jun2016
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:The current study was designed to evaluate the urease inhibitory profile of extract and fractions ofPistacia atlanticassp. cabulica Stocks followed by bioactivity-guided isolated compounds. The crude extract was found significantly active with urease inhibitor (95.40% at 0.2 mg/mL) with IC50values of 32.0 ± 0.28 μg/mL. Upon fractionation, ethyl acetate fraction displayed 100% urease inhibition with IC50values of 19.9 ± 0.51 μg/mL at 0.2 mg/mL. However,n-hexane and chloroform fractions exhibited insignificant urease inhibition. Similarly, the isolated compound, transilitin (1) and dihydro luteolin (2) demonstrated marked urease attenuation with 95 and 98% respectively, at 0.15 mg/mL. Both the isolated compounds showed marked potency with IC50values of 8.54 ± 0.54 and 9.58 ± 2.22 μg/mL, respectively. In short, both the extract and fractions and isolated compounds showed marked urease inhibition and thus a useful natural source of urease inhibition. Graphical abstract showing the imagePistacia atlantica, chemical structure of isolated compounds and urease enzyme.